Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer

Abstract Lipopolysaccharide (LPS) as an important inflammatory mediator activates the innate/adaptive immune system. The existence of LPS in pancreatic ductal adenocarcinoma (PDAC) has been reported, however, its biological function in PDAC remains unclear. Here, we demonstrated that circulating and...

Full description

Bibliographic Details
Main Authors: Hanlin Yin, Ning Pu, Qiangda Chen, Jicheng Zhang, Guochao Zhao, Xuefeng Xu, Dansong Wang, Tiantao Kuang, Dayong Jin, Wenhui Lou, Wenchuan Wu
Format: Article
Language:English
Published: Nature Publishing Group 2021-10-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-021-04293-4
_version_ 1798035174247628800
author Hanlin Yin
Ning Pu
Qiangda Chen
Jicheng Zhang
Guochao Zhao
Xuefeng Xu
Dansong Wang
Tiantao Kuang
Dayong Jin
Wenhui Lou
Wenchuan Wu
author_facet Hanlin Yin
Ning Pu
Qiangda Chen
Jicheng Zhang
Guochao Zhao
Xuefeng Xu
Dansong Wang
Tiantao Kuang
Dayong Jin
Wenhui Lou
Wenchuan Wu
author_sort Hanlin Yin
collection DOAJ
description Abstract Lipopolysaccharide (LPS) as an important inflammatory mediator activates the innate/adaptive immune system. The existence of LPS in pancreatic ductal adenocarcinoma (PDAC) has been reported, however, its biological function in PDAC remains unclear. Here, we demonstrated that circulating and tumoral LPS was significantly increased by intestinal leakage in the orthotopic murine PDAC model, and LPS administration promoted T cell infiltration but exhaustion paradoxically in the subcutaneous murine PDAC model. By bioinformatic analysis, Toll-like receptor 4 (TLR4), LPS receptor, was further found to enrich in immune tolerance signaling in PDAC tissues. Then, a significant positive correlation was found between TLR4 and programmed death ligand-1 (PD-L1) in clinical PDAC tissues, as well as serum LPS and tumoral PD-L1. Meanwhile, LPS stimulation in vitro and in vivo obviously upregulated tumor PD-L1 expression, and effectively promoted cancer cells resistance to T cell cytotoxicity. Mechanistically, the activation of TLR4/MyD88/AKT/NF-κB cascade was found to participate in LPS mediated PD-L1 transcription via binding to its promoter regions, which was enhanced by crosstalk between NF-κB and AKT pathways. Finally, PD-L1 blockade could significantly reverse LPS-induced immune escape, and synergized with LPS treatment. Taken together, LPS can remodel tumor microenvironment, and synergize with PD-L1 blockade to suppress tumor growth, which may be a promising comprehensive strategy for PDAC.
first_indexed 2024-04-11T20:54:36Z
format Article
id doaj.art-4144d0bf664a42c0ab804c74e75fe128
institution Directory Open Access Journal
issn 2041-4889
language English
last_indexed 2024-04-11T20:54:36Z
publishDate 2021-10-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj.art-4144d0bf664a42c0ab804c74e75fe1282022-12-22T04:03:43ZengNature Publishing GroupCell Death and Disease2041-48892021-10-01121111410.1038/s41419-021-04293-4Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancerHanlin Yin0Ning Pu1Qiangda Chen2Jicheng Zhang3Guochao Zhao4Xuefeng Xu5Dansong Wang6Tiantao Kuang7Dayong Jin8Wenhui Lou9Wenchuan Wu10Department of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityDepartment of General Surgery, Zhongshan Hospital, Fudan UniversityAbstract Lipopolysaccharide (LPS) as an important inflammatory mediator activates the innate/adaptive immune system. The existence of LPS in pancreatic ductal adenocarcinoma (PDAC) has been reported, however, its biological function in PDAC remains unclear. Here, we demonstrated that circulating and tumoral LPS was significantly increased by intestinal leakage in the orthotopic murine PDAC model, and LPS administration promoted T cell infiltration but exhaustion paradoxically in the subcutaneous murine PDAC model. By bioinformatic analysis, Toll-like receptor 4 (TLR4), LPS receptor, was further found to enrich in immune tolerance signaling in PDAC tissues. Then, a significant positive correlation was found between TLR4 and programmed death ligand-1 (PD-L1) in clinical PDAC tissues, as well as serum LPS and tumoral PD-L1. Meanwhile, LPS stimulation in vitro and in vivo obviously upregulated tumor PD-L1 expression, and effectively promoted cancer cells resistance to T cell cytotoxicity. Mechanistically, the activation of TLR4/MyD88/AKT/NF-κB cascade was found to participate in LPS mediated PD-L1 transcription via binding to its promoter regions, which was enhanced by crosstalk between NF-κB and AKT pathways. Finally, PD-L1 blockade could significantly reverse LPS-induced immune escape, and synergized with LPS treatment. Taken together, LPS can remodel tumor microenvironment, and synergize with PD-L1 blockade to suppress tumor growth, which may be a promising comprehensive strategy for PDAC.https://doi.org/10.1038/s41419-021-04293-4
spellingShingle Hanlin Yin
Ning Pu
Qiangda Chen
Jicheng Zhang
Guochao Zhao
Xuefeng Xu
Dansong Wang
Tiantao Kuang
Dayong Jin
Wenhui Lou
Wenchuan Wu
Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer
Cell Death and Disease
title Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer
title_full Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer
title_fullStr Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer
title_full_unstemmed Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer
title_short Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer
title_sort gut derived lipopolysaccharide remodels tumoral microenvironment and synergizes with pd l1 checkpoint blockade via tlr4 myd88 akt nf κb pathway in pancreatic cancer
url https://doi.org/10.1038/s41419-021-04293-4
work_keys_str_mv AT hanlinyin gutderivedlipopolysaccharideremodelstumoralmicroenvironmentandsynergizeswithpdl1checkpointblockadeviatlr4myd88aktnfkbpathwayinpancreaticcancer
AT ningpu gutderivedlipopolysaccharideremodelstumoralmicroenvironmentandsynergizeswithpdl1checkpointblockadeviatlr4myd88aktnfkbpathwayinpancreaticcancer
AT qiangdachen gutderivedlipopolysaccharideremodelstumoralmicroenvironmentandsynergizeswithpdl1checkpointblockadeviatlr4myd88aktnfkbpathwayinpancreaticcancer
AT jichengzhang gutderivedlipopolysaccharideremodelstumoralmicroenvironmentandsynergizeswithpdl1checkpointblockadeviatlr4myd88aktnfkbpathwayinpancreaticcancer
AT guochaozhao gutderivedlipopolysaccharideremodelstumoralmicroenvironmentandsynergizeswithpdl1checkpointblockadeviatlr4myd88aktnfkbpathwayinpancreaticcancer
AT xuefengxu gutderivedlipopolysaccharideremodelstumoralmicroenvironmentandsynergizeswithpdl1checkpointblockadeviatlr4myd88aktnfkbpathwayinpancreaticcancer
AT dansongwang gutderivedlipopolysaccharideremodelstumoralmicroenvironmentandsynergizeswithpdl1checkpointblockadeviatlr4myd88aktnfkbpathwayinpancreaticcancer
AT tiantaokuang gutderivedlipopolysaccharideremodelstumoralmicroenvironmentandsynergizeswithpdl1checkpointblockadeviatlr4myd88aktnfkbpathwayinpancreaticcancer
AT dayongjin gutderivedlipopolysaccharideremodelstumoralmicroenvironmentandsynergizeswithpdl1checkpointblockadeviatlr4myd88aktnfkbpathwayinpancreaticcancer
AT wenhuilou gutderivedlipopolysaccharideremodelstumoralmicroenvironmentandsynergizeswithpdl1checkpointblockadeviatlr4myd88aktnfkbpathwayinpancreaticcancer
AT wenchuanwu gutderivedlipopolysaccharideremodelstumoralmicroenvironmentandsynergizeswithpdl1checkpointblockadeviatlr4myd88aktnfkbpathwayinpancreaticcancer